NCT02212314

Brief Summary

The investigators will conduct a pilot study investigating the effectiveness of a computerized response inhibition training program at reducing the response inhibition difficulties often seen in children with Williams syndrome ages 10-17. The investigators hypothesize that after completing the training program, children with Williams syndrome will show improvement on computerized measures of response inhibition and on parent measures of impulsivity.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
25

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started May 2014

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2014

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

August 6, 2014

Completed
2 days until next milestone

First Posted

Study publicly available on registry

August 8, 2014

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2016

Completed
Last Updated

May 31, 2017

Status Verified

May 1, 2017

Enrollment Period

2 years

First QC Date

August 6, 2014

Last Update Submit

May 30, 2017

Conditions

Keywords

Response Inhibition, Williams Syndrome

Outcome Measures

Primary Outcomes (1)

  • Cognitive Inhibition Tasks

    Three measures of response inhibition that were administered to children at pre-test will be administered after the 5-7-week training and again at a 3-month follow-up. Measures include computer-administered Motor Stroop task, Stop Signal task, and Go/No-Go Task.

    5-7 weeks and 3 months

Secondary Outcomes (6)

  • Conners-3

    5-7 weeks and 3 months

  • Emotion Regulation Checklist

    5-7 weeks and 3 months

  • Positive and Negative Affect Scale

    5-7 weeks and 3 months

  • Question-Asking Questionnaire

    5-7 weeks and 3 months

  • Spence Children's Anxiety Scale

    5-7 weeks, 3 months

  • +1 more secondary outcomes

Other Outcomes (2)

  • Treatment Acceptability Questionnaire

    5-7 weeks

  • Treatment Evaluation Inventory

    5-7 weeks

Study Arms (2)

Response Inhibition Training

EXPERIMENTAL

Treatment group will receive immediate treatment after pre-test.

Behavioral: Response Inhibition Training

Waitlist Crossover

NO INTERVENTION

Waitlist group will not receive intervention while treatment group is active, but waitlist group will be offered treatment after post-test is completed.

Interventions

Computerized response inhibition training will be delivered via the Internet for 10 individual sessions.

Response Inhibition Training

Eligibility Criteria

Age10 Years - 17 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Williams syndrome (diagnosed with genetic testing)
  • Ages 10-17
  • First language and main language spoken in the home is English
  • Possess computer in the home that has internet access, and a second electronic device with access to Skype (e.g., smartphone, ipad, additional computer, ipod touch)

You may not qualify if:

  • First language and main language spoken in the home is NOT English (because study measures and instructions are all in English)
  • No computer in the home with internet access (because the study is being conducted via the internet)
  • Comorbid severe illnesses or major surgery within the past 6 months
  • Four or more previous sessions of inhibition training

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Wisconsin-Milwaukee Child Neurodevelopment Research Lab

Milwaukee, Wisconsin, 53211, United States

Location

MeSH Terms

Conditions

Williams Syndrome

Condition Hierarchy (Ancestors)

Intellectual DisabilityNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesAortic Stenosis, SupravalvularAortic Valve StenosisAortic Valve DiseaseHeart Valve DiseasesHeart DiseasesCardiovascular DiseasesChromosome DisordersCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesGenetic Diseases, Inborn

Study Officials

  • Bonita P Klein-Tasman, Ph.D.

    University of Wisconsin, Milwaukee

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

August 6, 2014

First Posted

August 8, 2014

Study Start

May 1, 2014

Primary Completion

May 1, 2016

Study Completion

May 1, 2016

Last Updated

May 31, 2017

Record last verified: 2017-05

Locations